Results 221 to 230 of about 562,936 (248)

Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trial

, 2011
C. Zadikoff, P. Wadia, J. Miyasaki, Robert Chen, A. Lang, J. So, S. Fox   +6 more
semanticscholar   +1 more source

SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists.

Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1999
To examine the acute actions of the CB1 cannabinoid receptor antagonist SR141716A [N-piperidino-5-(4-chlorophenyl)- 1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide] on typical behavioral pattern of psychoactive cannabinoids in rats.At different time after injection the tail-flick response latency, the rectal temperature, the locomotor activity ...
COSTA, BARBARA SIMONA, Colleoni, M.
openaire   +2 more sources

Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors

, 2013
G. Gobbi
semanticscholar   +1 more source

Role of residual CB1 receptor agonist activity in the hemodynamic profile of CB2 agonists

Journal of Pharmacological and Toxicological Methods, 2011
Patricia N. Banfor, Philip Zocharski, Betty Yao, Michael Dart, Michael Meyer, Andrew King   +5 more
openaire   +1 more source

Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists

Bioorganic and Medicinal Chemistry Letters, 2006
Alison M Strack, Donald J Marsh, D Sloan Stribling   +2 more
exaly  

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression.

Best practice & research. Clinical endocrinology & metabolism, 2009
F. Moreira, M. Grieb, B. Lutz
semanticscholar   +1 more source

1H-IMIDAZOLE DERIVATIVES HAVING CB1 AGONISTIC, CB1 PARTIAL AGONISTIC OR CB1- ANTAGONISTIC ACTIVITY

2003
KRUSE CORNELIS G, LANGE JOSEPHUS H M, HERREMANS ARNOLDUS H J, VAN STUIVENBERG HERMAN H   +3 more
openaire   +4 more sources

Design, synthesis, and structure–activity relationships of indole-3-heterocycles as agonists of the CB1 receptor

Bioorganic and Medicinal Chemistry Letters, 2011
Neil Steven Keddie, Takao Kiyoi
exaly  

The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists.

Journal of Pharmacology and Experimental Therapeutics, 2009
Kathryn A. Seely, M. S. Levi, P. Prather
semanticscholar   +1 more source

Pharmacology of cannabinoid CB1 and CB2 receptors.

Pharmacology and Therapeutics, 1997
R. Pertwee
semanticscholar   +1 more source